Google Alert - cannabidiol for epilepsy

	cannabidiol for epilepsy Daily update ⋅ August 4, 2020
	NEWS
	FDA Approves Cannabidiol for Tuberous Sclerosis Complex Medscape The drug was approved by the FDA in 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut ... Flag as irrelevant
	Epidiolex Now Available in US for Dravet, LGS Patients Age 1 and Older Dravet Syndrome News The cannabidiol was found to be efficient and have an acceptable safety profile as add-on anti-epileptic treatment in people with Dravet — at a dose of ... Flag as irrelevant
	Billion Dollar Cannabidiol Infused Products Market Growing Usage Continues to Skyrocket PRNewswire ... U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol) oral solution to treat seizures associated with tuberous sclerosis ... Flag as irrelevant
	Cannabidiol Market Size to Exceed $22 Bn By 2026 Story of Future It works in medical circumstances, such as inflammation, pain, sleep, epilepsy, schizophrenia, anorexia and multiple sclerosis. CBD's infused products ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback